|07:00 28-Aug-2012||AZN||European Commission approves Zinforo||RNS||-0.88%|
|07:00 28-Aug-2012||AZN||Pascal Soriot appointed CEO||RNS||-0.88%|
|07:00 28-Aug-2012||AZN||Transaction in Own Shares||RNS||-0.88%|
|16:00 24-Aug-2012||AZN||Director/PDMR Shareholding||RNS||-0.68%|
|07:00 24-Aug-2012||AZN||Transaction in Own Shares||RNS||-0.68%|
|07:00 23-Aug-2012||AZN||Transaction in Own Shares||RNS||-0.42%|
|07:00 22-Aug-2012||AZN||Transaction in Own Shares||RNS||-0.87%|
|07:00 21-Aug-2012||AZN||Transaction in Own Shares||RNS||-1.20%|
|07:00 20-Aug-2012||AZN||Transaction in Own Shares||RNS||-1.27%|
|07:00 17-Aug-2012||AZN||Transaction in Own Shares||RNS||-1.21%|
|07:00 15-Aug-2012||AZN||Transaction in Own Shares||RNS||-0.45%|
|07:00 14-Aug-2012||AZN||Partners Pfizer for over-the-counter Nexium||RNS||-0.02%|
|12:45 09-Aug-2012||AZN||Bristol-Myers Squibb completes purchase of Amylin||RNS||-1.53%|
|07:00 06-Aug-2012||AZN||Transaction in Own Shares||RNS||-0.98%|
|07:00 03-Aug-2012||AZN||Transaction in Own Shares||RNS||+0.28%|
|07:00 02-Aug-2012||AZN||Transaction in Own Shares||RNS||+1.90%|
|16:00 01-Aug-2012||AZN||Total Voting Rights||RNS||+2.90%|
|14:00 01-Aug-2012||AZN||Director/PDMR Shareholding||RNS||+2.90%|
|07:00 01-Aug-2012||AZN||Transaction in Own Shares||RNS||+2.90%|
|07:00 31-Jul-2012||AZN||Transaction in Own Shares||RNS||+3.91%|
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
You will be redirected in five seconds